Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $23.32 Million Holdings in The Cigna Group (NYSE:CI)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in The Cigna Group (NYSE:CIFree Report) by 0.2% in the first quarter, according to its most recent filing with the SEC. The fund owned 64,213 shares of the health services provider’s stock after acquiring an additional 133 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in The Cigna Group were worth $23,322,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of CI. Norges Bank bought a new stake in shares of The Cigna Group during the 4th quarter valued at about $1,006,348,000. Focused Investors Fund L P acquired a new stake in shares of The Cigna Group during the 1st quarter worth approximately $205,529,000. Cerity Partners LLC lifted its position in shares of The Cigna Group by 1,039.4% during the 4th quarter. Cerity Partners LLC now owns 590,063 shares of the health services provider’s stock valued at $176,694,000 after acquiring an additional 538,274 shares during the period. Jennison Associates LLC boosted its position in shares of The Cigna Group by 127.3% during the 4th quarter. Jennison Associates LLC now owns 566,233 shares of the health services provider’s stock worth $169,558,000 after purchasing an additional 317,081 shares in the last quarter. Finally, International Assets Investment Management LLC grew its stake in shares of The Cigna Group by 21,324.4% in the 4th quarter. International Assets Investment Management LLC now owns 285,801 shares of the health services provider’s stock valued at $85,583,000 after buying an additional 284,467 shares during the period. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at The Cigna Group

In related news, insider Noelle K. Eder sold 10,700 shares of the business’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $348.47, for a total value of $3,728,629.00. Following the completion of the sale, the insider now owns 15,824 shares in the company, valued at approximately $5,514,189.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the business’s stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $348.71, for a total value of $2,073,429.66. Following the sale, the senior vice president now directly owns 2,595 shares of the company’s stock, valued at $904,902.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Noelle K. Eder sold 10,700 shares of the stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $348.47, for a total transaction of $3,728,629.00. Following the sale, the insider now directly owns 15,824 shares in the company, valued at $5,514,189.28. The disclosure for this sale can be found here. Insiders sold a total of 22,988 shares of company stock worth $7,975,726 over the last three months. 0.60% of the stock is owned by insiders.

The Cigna Group Stock Performance

CI stock traded up $5.12 during midday trading on Wednesday, reaching $344.83. 733,137 shares of the company’s stock traded hands, compared to its average volume of 1,591,470. The firm has a market capitalization of $97.96 billion, a PE ratio of 27.90, a price-to-earnings-growth ratio of 1.01 and a beta of 0.52. The company has a 50-day moving average price of $335.84 and a two-hundred day moving average price of $336.08. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $365.71. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.71 and a current ratio of 0.71.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.17 by $0.30. The firm had revenue of $57.25 billion for the quarter, compared to the consensus estimate of $56.59 billion. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The company’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same period in the prior year, the firm posted $5.41 earnings per share. As a group, equities analysts anticipate that The Cigna Group will post 28.47 EPS for the current year.

The Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th were issued a $1.40 dividend. The ex-dividend date was Tuesday, June 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.62%. The Cigna Group’s payout ratio is currently 45.98%.

Analysts Set New Price Targets

Several brokerages have issued reports on CI. Baird R W upgraded The Cigna Group to a “strong-buy” rating in a report on Thursday, May 30th. Piper Sandler assumed coverage on shares of The Cigna Group in a research report on Wednesday, June 26th. They issued an “overweight” rating and a $400.00 price target for the company. Cantor Fitzgerald restated an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a report on Wednesday, July 10th. StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Friday, July 12th. Finally, Oppenheimer upped their target price on shares of The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $376.20.

View Our Latest Research Report on The Cigna Group

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.